Salvage Radiotherapy Management Decisions in Postprostatectomy Patients with Recurrent Prostate Cancer Based on
18F-fluciclovine
PET/CT
management change
prostate cancer
radiotherapy
Journal
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ISSN: 1535-5667
Titre abrégé: J Nucl Med
Pays: United States
ID NLM: 0217410
Informations de publication
Date de publication:
01 08 2021
01 08 2021
Historique:
received:
16
09
2020
accepted:
14
12
2020
pubmed:
1
2
2021
medline:
6
1
2022
entrez:
31
1
2021
Statut:
ppublish
Résumé
Imaging with novel PET radiotracers has significantly influenced radiotherapy decision making and radiation planning in patients with recurrent prostate cancer (PCa). The purpose of this analysis was to report the final results for management decision changes based on
Identifiants
pubmed: 33517323
pii: jnumed.120.256784
doi: 10.2967/jnumed.120.256784
pmc: PMC8833876
doi:
Substances chimiques
Carboxylic Acids
0
Cyclobutanes
0
fluciclovine F-18
38R1Q0L1ZE
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1089-1096Subventions
Organisme : NCI NIH HHS
ID : R01 CA169188
Pays : United States
Informations de copyright
© 2021 by the Society of Nuclear Medicine and Molecular Imaging.
Références
J Nucl Med. 2020 Jun;61(6):866-872
pubmed: 31676727
J Urol. 2017 Mar;197(3 Pt 1):676-683
pubmed: 27746282
J Clin Oncol. 2007 May 20;25(15):2035-41
pubmed: 17513807
Eur Urol. 2021 Feb;79(2):263-282
pubmed: 33039206
Eur Urol Focus. 2019 Jul;5(4):550-560
pubmed: 29133278
Radiol Med. 2020 Jul;125(7):668-673
pubmed: 32166718
Pract Radiat Oncol. 2020 Sep - Oct;10(5):354-362
pubmed: 32464368
J Natl Compr Canc Netw. 2019 May 1;17(5):479-505
pubmed: 31085757
Eur J Nucl Med Mol Imaging. 2016 Sep;43(10):1773-83
pubmed: 27091135
Urology. 2003 Mar;61(3):607-11
pubmed: 12639656
AJR Am J Roentgenol. 2019 Oct;213(4):851-858
pubmed: 31216198
Lancet. 2020 Apr 11;395(10231):1208-1216
pubmed: 32209449
Appl Radiat Isot. 2003 Jun;58(6):657-66
pubmed: 12798374
Clin Nucl Med. 2017 Jan;42(1):e22-e28
pubmed: 27749412
AJR Am J Roentgenol. 2020 Mar;214(3):641-648
pubmed: 31939697
Front Oncol. 2016 Mar 31;6:73
pubmed: 27065024
Rev Urol. 2001 Spring;3(2):72-84
pubmed: 16985694
Int J Radiat Oncol Biol Phys. 2020 Jun 1;107(2):316-324
pubmed: 32068113
Int J Radiat Oncol Biol Phys. 2012 Jul 1;83(3):e353-62
pubmed: 22483697
J Am Coll Radiol. 2012 Apr;9(4):233-8
pubmed: 22469373
Cancer Res Treat. 2010 Mar;42(1):1-11
pubmed: 20369045
Lancet Oncol. 2019 Sep;20(9):1286-1294
pubmed: 31375469
J Urol. 2014 May;191(5):1446-53
pubmed: 24144687
Eur J Nucl Med Mol Imaging. 2019 Jan;46(1):11-19
pubmed: 29905907
Int J Radiat Oncol Biol Phys. 2020 Dec 1;108(5):1397
pubmed: 33427655
Br J Radiol. 2009 Feb;82(974):148-56
pubmed: 19168692
AJR Am J Roentgenol. 2009 Jun;192(6):1455-70
pubmed: 19457806
Clin Oncol (R Coll Radiol). 2020 Mar;32(3):156-162
pubmed: 32035581
J Nucl Med. 2017 Mar;58(3):412-418
pubmed: 27609792
J Nucl Med. 2019 Nov;60(11):1587-1593
pubmed: 30979820
BJU Int. 2017 Aug;120(2):197-203
pubmed: 27981732
Eur J Nucl Med Mol Imaging. 2014 Dec;41(12):2222-31
pubmed: 25182750
J Natl Compr Canc Netw. 2019 May 1;17(5):506-513
pubmed: 31085758
Radiother Oncol. 2011 May;99(2):193-200
pubmed: 21620494
JAMA. 2005 Jul 27;294(4):433-9
pubmed: 16046649
Clin Nucl Med. 2019 Oct;44(10):e566-e573
pubmed: 31283605
J Urol. 2003 Feb;169(2):517-23
pubmed: 12544300
Clin Nucl Med. 2017 May;42(5):e242-e246
pubmed: 28240662